Scintigraphic Localization of Pheochromocytoma
- 2 July 1981
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 305 (1) , 12-17
- https://doi.org/10.1056/nejm198107023050103
Abstract
We used a new radiopharmaceutical agent, [131I]meta-iodobenzylguanidine ([131I]MIBG), to produce scintigraphic images of pheochromocytomas in eight patients. One day or more after injection, the only normal organ that displayed distinct concentrations of radioactivity was the urinary bladder. The [131I]MIBG was probably concentrated in adrenergic vesicles; in tissues where vesicles are numerous, such as pheochromocytomas, the radionuclide was retained for days.This publication has 17 references indexed in Scilit:
- Physiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine SystemNew England Journal of Medicine, 1980
- PheochromocytomaArchives of Surgery, 1980
- CT for pheochromocytoma diagnosisAmerican Journal of Roentgenology, 1980
- Circulating and Urinary Catecholamines in PheochromocytomaNew England Journal of Medicine, 1979
- SELECTIVE VENOUS SAMPLING IN THE DIAGNOSIS AND LOCALIZATION OF PHAEOCHROMOCYTOMAClinical Endocrinology, 1979
- Localization of Pheochromocytoma by Computed TomographyNew England Journal of Medicine, 1978
- Rigorous biochemical criteria for the diagnosis of pheochromocytomaJournal of Surgical Research, 1973
- Angiography of Extra-Adrenal PheochromocytomasJournal of Urology, 1972
- Techniques, usefulness, and hazards of arteriography of pheochromocytoma. Review of 99 casesJAMA, 1968
- Localization of Pheochromocytomata by Caval CatheterizationArchives of Surgery, 1967